Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия ela12@yandex.ru
Список исп. литературыСкрыть список 1. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19): клинические рекомендации. Минздрав России. Версия 15 (22.02.2022). URL: https://static-0.minzdrav.gov.ru/ system/attachments/attaches/000/059/392/original/ВМР_COVID-19_V15.pdf [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19): klinicheskie rekomendatsii. Minzdrav Rossii. Versiia 15 (22.02.2022). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/VMR_COVID-19_V15.pdf (in Russian).] 2. Острые респираторные вирусные инфекции (ОРВИ) у взрослых. Клинические рекомендации. Минздрав России. 2021. URL: https://www.rnmot.ru/public/uploads/RNMOT/clinical/2021/КР%20ОРВИ.pdf [Ostrye respiratornye virusnye infektsii (ORVI) u vzroslykh. Klinicheskie rekomendatsii. Minzdrav Rossii. 2021. URL: https://www.rnmot.ru/public/uploads/RNMOT/clinical/2021/KR ORVI.pdf (in Russian).] 3. Xu X, Yu C, Qu J et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020; 47 (5): 1275–80. DOI: 10.1007/s00259-020-04735-9 4. Hani C, Trieu NH, Saab I et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020; 101 (5): 263–8. DOI: 10.1016/j.diii.2020.03.014 5. Gül Ü. COVID-19 and dermatology. Turk J Med Sci 2020; 50 (8): 1751–9. DOI: 10.3906/sag-2005-182 6. Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L et al. On Behalf Of The CAMFiC Long Covid-Study Group. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18 (8): 4350. DOI: 10.3390/ijerph18084350 7. Grifoni A, Weiskopf D, Ramirez SI et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell 2020; 181 (7): 1489–1501.e15. DOI: 10.1016/j.cell.2020.05.015 8. Larici AR, Cicchetti G, Marano R et al. Multimodality imaging of COVID-19 pneumonia: from diagnosis to follow-up. A comprehensive review. Eur J Radiol 2020; 131: 109217. DOI: 10.1016/j.ejrad. 2020.109217 9. Puzyrenko A, Felix JC, Ledeboer NA et al. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis. Pathology 2021; 2022; 54 (4): 404–8. DOI: 10.1016/j.pathol.2021.09.005 10. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020; 8 (8): 807–15. DOI: 10.1016/S2213-2600(20)30225-3 11. Wu LP, Wang NC, Chang YH et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis 2007; 13 (10): 1562–4. DOI: 10.3201/eid1310.070576 12. Chen P, Nirula A, Heller B et al; BLAZE-1 Investigators. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med 2021; 384 (3): 229–37. DOI: 10.1056/NEJMoa2029849 13. Frieman M, Heise M, Baric R. SARS coronavirus and innate immunity. Virus Res 2008; 133 (1): 101–12. DOI: 10.1016/j.virusres. 2007.03.015 14. Bastard P, Rosen LB, Zhang Q et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370 (6515): eabd4585. DOI: 10.1126/science.abd4585 15. Le Bert N, Tan AT, Kunasegaran K et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020; 584 (7821): 457–62. DOI: 10.1038/s41586-020-2550-z 16. Heald-Sargent T, Muller WJ, Zheng X et al. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19). JAMA Pediatr 2020; 174 (9): 902–3. DOI: 10.1001/jamapediatrics.2020.3651 17. Smorenberg A, Peters EJ, van Daele P et al. How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur J Intern Med 2021; 83: 1–5. DOI: 10.1016/j.ejim.2020.11.024 18. Poletti P, Tirani M, Cereda D et al; ATS Lombardy COVID-19 Task Force. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy. JAMA Netw Open 2021; 4 (3): e211085. DOI: 10.1001/jamanetworkopen.2021.1085 19. Norman DC. Fever in the elderly. Clin Infect Dis 2000; 31 (1): 148–51. DOI: 10.1086/313896 20. Guo T, Shen Q, Guo W et al. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology 2020; 66 (5): 467–75. DOI: 10.1159/000508734 21. Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY) 2020; 12 (10): 9959–81. DOI: 10.18632/aging.103344 22. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013; 2013 (1): CD000980. DOI: 10.1002/14651858.CD000980.pub4 23. Pascarella G, Strumia A, Piliego C et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288 (2): 192–206. DOI: 10.1111/joim.13091 24. Wu X, Liu X, Zhou Y et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9 (7): 747–54. DOI: 10.1016/S2213-2600(21)00174-0 25. Коденцова В.М., Рисник Д.В., Никитюк Д.Б., Тутельян В.А. Витаминно-минеральные комплексы в лечебном питании. Consilium Medicum. 2017; 19 (12): 76–83. DOI: 10.26442/2075-1753_19.12.76-83 [Kodentsova V.M., Risnik D.V., Nikitiuk D.B., Tutel'ian V.A. Vitaminno-mineral'nye kompleksy v lechebnom pitanii. Consilium Medicum. 2017; 19 (12): 76–83. DOI: 10.26442/2075-1753_19.12.76-83 (in Russian).] 26. Gómez E, Quidel S, Bravo-Soto G, Ortigoza Á. Does vitamin C prevent the common cold? Medwave 2018; 18 (4): e7235. DOI: 10.5867/medwave.2018.04.7236 27. Quidel S, Gómez E, Bravo-Soto G, Ortigoza Á. What are the effects of vitamin C on the duration and severity of the common cold? Medwave 2018; 18 (6): e7261. DOI: 10.5867/medwave.2018.06.7260 28. Ran L, Zhao W, Wang J et al. Extra Dose of Vitamin C Based on a Daily Supplementation Shortens the Common Cold: A Meta-Analysis of 9 Randomized Controlled Trials. Biomed Res Int 2018; 2018: 1837634. DOI: 10.1155/2018/1837634 29. Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health 2021; 6 (1): e003176. DOI: 10.1136/bmjgh-2020-003176 30. Shrestha DB, Budhathoki P, Sedhai YR et al. Vitamin C in Critically Ill Patients: An Updated Systematic Review and Meta-Analysis. Nutrients 2021; 13 (10): 3564. DOI: 10.3390/nu13103564 31. Hemilä H, Chalker E. Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis. Nutrients 2019; 11 (4): 708. DOI: 10.3390/nu11040708 32. Kwak SG, Choo YJ, Chang MC. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis. Complement Ther Med 2022; 64: 102797. DOI: 10.1016/j.ctim.2021.102797 33. Rawat D, Roy A, Maitra S et al. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2021; 15 (6): 102324. DOI: 10.1016/j.dsx.2021.102324 34. Hemilä H. Vitamin C intake and susceptibility to the common cold. Br J Nutr 1997; 77 (1): 59–72. DOI: 10.1017/s0007114500002889 35. Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther 2006; 31 (4): 309–19. DOI: 10.1111/j.1365-2710.2006.00754.x 36. Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: A history of errors, failures and false decisions. Eur J Pain 2015; 19 (7): 953–65. DOI: 10.1002/ejp.621 37. Kantor TG. Ibuprofen. Ann Intern Med 1979; 91 (6): 877 82. DOI: 10.7326/0003-4819-91-6-877 38. Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 2000; 22 (5): 500–48. DOI: 10.1016/S0149-2918(00)80043-0 39. Cooper SA. Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med 1981; 141 (3 Spec No): 282–5. DOI: 10.1001/archinte.141.3.282 40. Derry S, Wiffen PJ, Moore RA. Aspirin for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev 2017; 1 (1): CD011888. DOI: 10.1002/14651858.CD011888.pub2 41. Schachtel BP, Fillingim JM, Beiter DJ et al. Rating scales for analgesics in sore throat. Clin Pharmacol Ther 1984; 36 (2): 151–6. DOI: 10.1038/clpt.1984.154 42. Schachtel BP, Fillingim JM, Thoden WR et al. Sore throat pain in the evaluation of mild analgesics. Clin Pharmacol Ther 1988; 44 (6): 704–11. DOI: 10.1038/clpt.1988.215 43. Bachert C, Chuchalin AG, Eisebitt R et al. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin Ther 2005; 27 (7): 993–1003. DOI: 10.1016j.clinthera.2005.06.002 44. Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158 (6): 521–6. DOI:10.1001/archpedi.158.6.521 45. Schachtel BP, Thoden WR. A placebo-controlled model for assaying systemic analgesics in children. Clin Pharmacol Ther 1993; 53 (5): 593–601. DOI:10.1038/clpt.1993.75 46. Cranswick N, Coghlan D. Paracetamol efficacy and safety in children: the first 40 years. Am J Ther 2000; 7 (2): 135–41. DOI:10.1097/ 00045391-200007020-00010 47. Зайцева О.В. Современные возможности профилактики и лечения острых респираторных заболеваний. РМЖ. 2011; 19 (23): 1458–61. URL: https://elibrary.ru/download/elibrary_20168443_ 81663491.pdf [Zaitseva O.V. Sovremennye vozmozhnosti profilaktiki i lecheniia ostrykh respiratornykh zabolevanii. RMZh. 2011; 19 (23): 1458–61. URL: https://elibrary.ru/download/elibrary_20168443_81663491.pdf (in Russian).] 48. Кунельская Н.Л., Туровский А.Б., Лучшева Ю.В. и др. Некоторые аспекты лечения острого ринита местными комплексными препаратами. Лечебное дело. 2017; 3: 37–43. URL: https://elibrary.ru/download/elibrary_30538680_39422433.pdf [Kunel'skaia N.L., Turovskii A.B., Luchsheva Iu.V. et al. Nekotorye aspekty lecheniia ostrogo rinita mestnymi kompleksnymi preparatami. Lechebnoe delo. 2017; 3: 37–43. URL: https://elibrary.ru/download/elibrary_30538680_39422433.pdf (in Russian).] 49. Atkinson HC, Potts AL, Anderson BJ. Potential cardiovascular adverse events when phenylephrine is combined with paracetamol: simulation and narrative review. Eur J Clin Pharmacol 2015; 71 (8): 931–8. DOI: 10.1007/s00228-015-1876-1 50. Atkinson HC, Stanescu I, Anderson BJ. Increased phenylephrine plasma levels with administration of acetaminophen. N Engl J Med 2014; 370 (12): 1171–2. DOI: 10.1056/NEJMc1313942 51. Picon PD, Costa MB, da Veiga Picon R et al. Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial. BMC Infect Dis 2013; 13: 556. DOI: 10.1186/1471-2334-13-556 52. Atkinson HC, Stanescu I, Salem II et al. Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers. Eur J Clin Pharmacol 2015; 71 (2): 151–8. DOI: 10.1007/s00228-014-1788-5 53. Gelotte CK. An open-label, randomized, four-treatment crossover study evaluating the effects of salt form, acetaminophen, and food on the pharmacokinetics of phenylephrine. Regul Toxicol Pharmacol 2018; 95: 333–8. DOI: 10.1016/j.yrtph.2018.04.008 54. Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020; 69 (12): 1181–9. DOI: 10.1007/s00011-020-01401-6. PMID: 32918567; PMCID: PMC7486586. 55. Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health 2021; 18 (10): 5329. DOI: 10.3390 /ijerph18105329. PMID: 34067776; PMCID: PMC8156194.